We are live on
!
Find out more
BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$5.12B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+14.08%
1 Year Est. Return
+27.39%
3 Year Est. Return
+99.4%
5 Year Est. Return
+123.97%
10 Year Est. Return
+508.14%
AUM
$3.85B
AUM Growth
+$469M
(+14%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.69%
Top 10 Holdings %
Top 10 Hldgs %
45.19%
Holding
284
New
13
Increased
74
Reduced
53
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$38.4M |
| 2 |
NVIDIA
NVDA
|
+$36M |
| 3 |
Merck
MRK
|
+$25.9M |
| 4 |
Waste Management
WM
|
+$22.2M |
| 5 |
Amazon
AMZN
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$28.2M |
| 2 |
Colgate-Palmolive
CL
|
+$27.4M |
| 3 |
Prologis
PLD
|
+$17.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.4M |
| 5 |
Equinix
EQIX
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.18% |
| 2 | Healthcare | 20.56% |
| 3 | Consumer Discretionary | 14.6% |
| 4 | Communication Services | 12.07% |
| 5 | Financials | 11.89% |
Similar funds
PA
BG
SCM
MIM
O
MS
NL
DDC
Bank Pictet & Cie (Europe)'s Q1 2024 Portfolio in Review
As of Q1 2024, Bank Pictet & Cie (Europe) held 284 positions worth $3.85B, up 14% from $3.38B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Bank Pictet & Cie (Europe)'s Q1 2024 filing shows 13 new, 74 increased, 53 reduced and 116 closed positions. Its largest new stake was Waste Management: 112,870 shares worth $24.1M. The largest sale was Teva Pharmaceuticals, an estimated $28.2M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bank Pictet & Cie (Europe)'s largest Q1 2024 buy was Waste Management: 112,870 shares worth $24.1M.
- Bank Pictet & Cie (Europe) added most to Microsoft in Q1 2024, an estimated $38.4M increase.
- Bank Pictet & Cie (Europe)'s biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17.4M.
- Bank Pictet & Cie (Europe) fully exited Teva Pharmaceuticals in Q1 2024, selling an estimated $28.2M.
- Bank Pictet & Cie (Europe)'s ten largest holdings make up 45% of its $3.85B portfolio in Q1 2024.
- Bank Pictet & Cie (Europe) opened 13 new positions and closed 116 in Q1 2024.
- Bank Pictet & Cie (Europe)'s portfolio value rose 14% quarter-over-quarter to $3.85B.
Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2024, filed 7 May 2024.